News
Dr. Brian Barnett shows the inside of the dosing room at Cleveland Clinic Lutheran where participants in a study looking at ...
Psychedelic drugs are seeing a surge of interest from mainstream medicine, and initial results suggest that ...
Taking LSD or magic mushrooms may not be the cause of schizotypal traits. Psychedelic drugs are experiencing a resurgence of ...
Use of psilocybin has increased among all age groups since some states decriminalized the hallucinogen in 2019.
Since 2019, these higher levels of psilocybin use reflected an increase of 188% among adults 30 and older and 44% among 18- ...
Psilocybin has been studied as a possible treatment for post-traumatic stress disorder (PTSD), depression and substance use ...
3d
News-Medical.Net on MSNSingle psychedelic dose boosts long-term cognitive flexibility in miceUniversity of Michigan researchers have found that certain psychedelic compounds improve the brain’s ability to adapt and ...
Use of psilocybin, the hallucinogenic chemical found in what is known as 'magic mushrooms,' has increased significantly nationwide since 2019, according to a new study.
The Cleveland Clinic is part of a multisite trial studying psilocybin to help patients with treatment-resistant depression.
A single psychedelic dose unexpectedly boosted long-lasting cognitive flexibility in mice, hinting at mental health benefits.
3d
Study Finds on MSNSingle Psychedelic Dose Shows Cognitive Boost Lasting WeeksLearn how psychedelics can enhance adaptability in the brain, improving learning and memory for conditions like PTSD.
14h
ZME Science on MSNMagic Mushroom Use Is Soaring in the U.S. With More Americans Turning to Psilocybin Than Cocaine or MethWith legal penalties waning and curiosity rising, psilocybin is gaining traction in the American psyche. Still, only 2% of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results